Clinical Trial

Empowering Narratives

Study acronym: EN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Background: The Russian invasion of Ukraine has resulted in forced displacement, with over 80,000 Ukrainian refugees now residing in Norway. This displacement has led to increased vulnerability to trauma and mental health challenges. Narrative Exposure Therapy (NET), a short-term trauma-focused intervention, has demonstrated efficacy in reducing PTSD symptoms among individuals exposed to organized violence and war. Aim: The protocol aims to assess the clinical effects of Narrative Exposure Therapy (NET) on PTSD and depression symptoms among Ukrainian refugees in Norway and to facilitate training and supervised practice for Ukrainian health professionals and workers in using NET. Methods: This study employs a pretest-posttest randomized controlled experimental design. Ukrainian health professionals and workers in Norway will receive standardized NET training through a digital course. Subsequently, they will treat Ukrainian refugees using NET under supervision. Participants will be screened and assessed at three time points: baseline, immediately after treatment, and at 6-month follow-up. Validated questionnaires in Ukrainian and Russian will be used: PHQ-9, ITQ, LEC-5, SHUT-D, and demographic questionnaire. Exclusion criteria include active psychotic spectrum disorders, neurodevelopmental disorders and concurrent trauma therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-08.
Trial Details
NCT Number NCT07062042
Lead Sponsor Kristiania University College
Collaborators: University of Konstanz, Oswaldo Cruz Foundation, Mental helse, Vårsta Diakoni, Norsk-Ukrainsk hjelpeorganisasjon, The Dam Foundation
Conditions PTSD - Post Traumatic Stress Disorder, Depression Disorders, Dissociation, Refugee
Enrollment 50 participants
Start Date 2025-03-01
Primary Completion 2025-12-20 (estimated)
Study Completion 2026-04-20 (estimated)
Updated on ClinicalTrials.gov 2025-08-17